Kurne, A. Et Al. 2008. Soluble trail and BAFF levels in multiple sclerosis during interferon-beta therapy. JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2 , 137-138.

Kurne, A., Aydin, O. F., Guec, D., Sayat, G., Canpinar, H., Yoeruebulut, M., ... KARABUDAK, R.(2008). Soluble trail and BAFF levels in multiple sclerosis during interferon-beta therapy. JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2, 137-138.

Kurne, Ash Et Al. "Soluble trail and BAFF levels in multiple sclerosis during interferon-beta therapy," JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2, 137-138, 2008

Kurne, Ash Et Al. "Soluble trail and BAFF levels in multiple sclerosis during interferon-beta therapy." JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2, pp.137-138, 2008

Kurne, A. Et Al. (2008) . "Soluble trail and BAFF levels in multiple sclerosis during interferon-beta therapy." JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2, pp.137-138.

@article{article, author={Ash Kurne Et Al. }, title={Soluble trail and BAFF levels in multiple sclerosis during interferon-beta therapy}, journal={JOURNAL OF NEUROIMMUNOLOGY}, year=2008, pages={137-138} }